EPISODE · Oct 4, 2018 · 29 MIN
Incorporating New IO Therapies - Biomarkers
from AUAUniversity · host American Urological Association
To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of adverse events, the AUA is producing a series of online activities for clinicians and other healthcare professionals. The 2018 series is comprised of a variety of activities, including four live webinars, webcasts and podcasts plus three podcast addressing the barriers to immunotherapy treatment of GU cancer. All activities are complimentary. Breaking Down the Barriers: Incorporating New IO Therapies Podcast Series - Biomarkers is the first podcast in a 3-part series. CME Available: https://auau.auanet.org/node/20962
What this episode covers
To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of adverse events, the AUA is producing a series of online activities for clinicians and other healthcare professionals. The 2018 series is comprised of a variety of activities, including four live webinars, webcasts and podcasts plus three podcast addressing the barriers to immunotherapy treatment of GU cancer. All activities are complimentary. Breaking Down the Barriers: Incorporating New IO Therapies Podcast Series - Biomarkers is the first podcast in a 3-part series. CME Available: https://auau.auanet.org/node/20962
NOW PLAYING
Incorporating New IO Therapies - Biomarkers
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.